The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Open accessAbstract
BACKGROUND: Human immunodeficiency virus (HIV) replication and immune activation may increase inflammation and coagulation biomarkers. Limited data exist comparing such biomarkers in persons with and without HIV infection. METHODS: For persons 45-76 years of age, levels of high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, D-dimer, and cystatin C were compared in 494 HIV-infected individuals in the Strategies for Management of Anti-Retroviral Therapy (SMART) study and 5386 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) study. For persons 33-44 years of age, hsCRP and IL-6 levels were compared in 287 participants in the SMART study and 3231 participants in the Coronary Artery Development in Young Adults (CARDIA) study. RESULTS: hsCRP and IL-6 levels were 55% (P < . 001) and 62 (P < . 001) higher among HIV-infected participants than among CARDIA study participants. Compared with levels noted in MESA study participants, hsCRP, IL-6, D-dimer, and cystatin C levels were 50%, 152%, 94%, and 27% higher, respectively (P < . 001, for each), among HIV-infected participants. HIV-infected participants receiving antiretroviral therapy who had HIV RNA levels 400 copies/mL had levels higher (by 21% to 60%) (P < . 001) than those in the general population, for all biomarkers. CONCLUSIONS: hsCRP, IL-6, D-dimer, and cystatin C levels are elevated in persons with HIV infection and remain so even after HIV RNA levels are suppressed with antiretroviral therapy. Additional research is needed on the pathophysiology of HIV-induced activation of inflammatory and coagulation pathways, to guide potential interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this therapy does not protect patients from the persistent immune activation, chronic inflammation, and excess risk of developing CVD and frailty131–135.”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [132]
In the citing paper
“Many (but not all) biomarkers associated with inflammation (e.g., IL-6, sCD14) and end-organ diseases common in seniors (e.g., cystatin C as a marker of declining renal function) are higher in antiretroviral-treated adults than uninfected adults (50).”
From HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationC-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citationAssociations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Self-citationCystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
Shlipak, M. G., Sarnak, M. J., Katz, R., Fried, L. F., Seliger, S. L., Newman, A. B., Siscovick, D. S., & Stehman‐Breen, C. O. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043161 · Cited by 1,241
Self-citationRelation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098
Self-citationMacy, E. M., Hayes, T. E., & Tracy, R. P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.52 · Cited by 797
Self-citation
Flagged first, then by citations
1 of the 33 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 870
Nabatanzi, R., Ssekamatte, P., Castelnuovo, B., Kambugu, A. D., & Nakanjako, D. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad539 · Cited by 10
Gama, T. G. V., Pires, F. R., Armada, L., & Gonçalves, L. S. (2016) · Journal of Endodontics · doi:10.1016/j.joen.2016.03.008 · Cited by 10
Metabolic Syndrome and HIV Infection
Swami, A. (2016) · Journal of HIV & Retro Virus · doi:10.21767/2471-9676.100014 · Cited by 10
Higher Levels of Cystatin C in HIV / AIDS Patients with Metabolic Syndrome
Dragović, G., Srdić, D., Al-Musalhi, K., Soldatović, I., Kušić, J., Jevtović, D., & Nair, D. R. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12919 · Cited by 10
Immunological age prediction in HIV-infected, ART-treated individuals
de Armas, L. R., Pallikkuth, S., Pan, L., Rinaldi, S., Pahwa, R., & Pahwa, S. G. (2021) · Aging · doi:10.18632/aging.203625 · Cited by 10
Moreira, F. D. L., Melli, P. P. D. S., Marques, M. P., Rocha, A., Nardotto, G. H. B., Duarte, G. G., & Lanchote, V. L. (2022) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2152 · Cited by 10
Singh, V. B., Wooten, A. K., Jackson, J. W., Maggirwar, S. B., & Kiebala, M. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0318-2 · Cited by 10
Sokalski, K. M., Chu, J., Mai, A. Y., Qiu, A. Q., Albert, A., Zanet, D. L., Côté, H. C. F., Maan, E. J., Pick, N., Prior, J. C., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12881 · Cited by 10
Lundgren, J. D., Baxter, J., Deeks, S. G., & Lane, H. C. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833f2ed6 · Cited by 10
Chastain, D. B., Franco‐Paredes, C., & Stover, K. R. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.978 · Cited by 10
Letizia, A. G., Eller, M. A., Polyak, C. S., Eller, L. A., Creegan, M., Dawson, P. M., Bryant, C., Kim, D., Crowell, T. A., Lombardi, K., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy509 · Cited by 10
HIV infection as a permanent, acquired risk factor for VTE
Bibas, M., Biava, G., & Antinori, A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.211-c1 · Cited by 10
Residual Immune Activation and Latency
Bruzzesi, E., & Sereti, I. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_118 · Cited by 9
Reno, T. A., Tarnus, L., Tracy, R. P., LANDAY, A. L., Sereti, I., Apetrei, C., & Pandrea, I. (2022) · Frontiers in Virology · doi:10.3389/fviro.2021.795373 · Cited by 9
Self-citationTang, Y.-F., Wang, Y., Xue, T.-J., Liu, G., Chen, Q., Zhao, W., Liu, Y.-Y., Chen, R.-Q., Chen, L., & Liu, J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s346200 · Cited by 9
Wang, N., Chen, H., & Lin, T. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.010 · Cited by 9
Transgender Women with HIV Demonstrate Unique Non-Alcoholic Fatty Liver Disease Profiles
Lake, J. E., Hyatt, A. N., Feng, H., Miao, H., Somasunderam, A., Utay, N. S., & Corey, K. E. (2023) · Transgender Health · doi:10.1089/trgh.2022.0182 · Cited by 11
Hishiya, N., Uno, K., Nakano, A., Konishi, M., Higashi, S., Eguchi, S., Ariyoshi, T., Matsumoto, A., Oka, K., Takahashi, M., et al. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.09.013 · Cited by 9
Hulgan, T., Boger, M. S., Liao, D. H., McComsey, G. A., WANKE, C. A., Mangili, A., Walmsley, S. L., McCreath, H. E., Milne, G. L., Sanchez, S. C., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/803095 · Cited by 9
Collins, S., & Geffen, N. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000024 · Cited by 10
Older HIV-infected adults: complex patients (III)—polypharmacy
Freedman, S. F., Johnston, C. D., Faragon, J. J., Siegler, E. L., & Carmen, T. D. (2018) · European Geriatric Medicine · doi:10.1007/s41999-018-0139-y · Cited by 9
Ding, Y., Duan, S., Ye, R., Yao, S., Cao, D., Yang, Y., Wang, J., Shi, Y., Zhang, Y., Li, P., et al. (2019) · HIV Medicine · doi:10.1111/hiv.12763 · Cited by 9
Trevillyan, J. M., Moser, C., Currier, J. S., & Sallam, T. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz765 · Cited by 9
Increasing procoagulant activity of circulating microparticles in patients living with HIV
Snopková, S., Matýšková, M., Havlíčková, K., Jarkovský, J., Svoboda, M., Zavřelová, J., Svačinka, R., Penka, M., & Husa, P. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.09.013 · Cited by 8
Sellers, C. J., & Wohl, D. A. (2014) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.05.004 · Cited by 9
Incident hypertension in older women and men with or at risk for HIV infection
Factor, S., Lo, Y., Schoenbaum, E. E., & Klein, R. (2013) · HIV Medicine · doi:10.1111/hiv.12010 · Cited by 9
Chichetto, N. E., Plankey, M. W., Sheps, D. S., Abraham, A. G., Chen, X., SHOPTAW, S. J., Kaplan, R. C., Post, W. S., & Cook, R. L. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.09.034 · Cited by 9
HIV infection is associated with upregulated circulating levels of the inflammaging miR-21-5p
Meseguer-Donlo, J., Soldado‐Folgado, J., Du, J., González‐Mena, A., Blasco-Hernando, F., Cañas‐Ruano, E., Nogués, X., Knobel, H., García‐Giralt, N., & Güerri‐Fernández, R. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.07.011 · Cited by 8
Capriotti, Z., & Klase, Z. A. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-024-01239-2 · Cited by 11
Wilkinson, J. D., Diamond, M. B., & Miller, T. L. (2011) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2011.06.006 · Cited by 8
Fibroblast Growth Factor 21 Is Elevated in HIV and Associated With Interleukin-6
Eckard, A. R., Hughes, H., Hagood, N. L., O’Riordan, M. A., Labbato, D. E., Kosco, J. C., Scott, S., & McComsey, G. A. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002285 · Cited by 8
Human Immunodeficiency Virus and Clonal Hematopoiesis
Vorri, S. C., Christodoulou, I., Karanika, S., & Karantanos, T. (2023) · Cells · doi:10.3390/cells12050686 · Cited by 9
Achhra, A. C., Amin, J., Sabin, C. A., Chu, H., Dunn, D. T., Kuller, L. H., Kovacs, J. A., Cooper, D. A., Emery, S., & Law, M. G. (2012) · AIDS · doi:10.1097/qad.0b013e328355d659 · Cited by 8
Self-citationImpact of HIV on lung tumorigenesis in an animal model
Kawabata, S., Heredia, A., Gills, J. J., Redfield, R., Dennis, P. A., & Bryant, J. (2015) · AIDS · doi:10.1097/qad.0000000000000588 · Cited by 8
Arribas, J. R., Hill, A., Xi, N., van Delft, Y., & Moecklinghoff, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks102 · Cited by 8
Raffetti, E., Donato, F., Castelli, F., Maggiolo, F., Carosi, G., & Quirós-Roldán, E. (2015) · Infectious Agents and Cancer · doi:10.1186/s13027-015-0032-y · Cited by 8
Inflammation Associates With Impaired Small Arterial Elasticity Early in HIV Disease
Peterson, T. E., Hullsiek, K. H., Engen, N. W., Kumarasamy, N., Lebech, A., Liappis, A. P., Papadopoulos, A., Polizzotto, M. N., Schreiner, P. J., Duprez, D. A., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy117 · Cited by 8
Self-citationMezoh, G., Lutchman, N., Worsley, C. M., Gededzha, M. P., Mayne, E. S., Martinson, N. A., Moore, P. L., & Crowther, N. J. (2021) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2021.0052 · Cited by 8
Polanka, B. M., Gupta, S. K., So‐Armah, K., Freiberg, M. S., Zapolski, T. C. B., Hirsh, A. T., & Stewart, J. C. (2022) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab119 · Cited by 8
Lombardi, F., Belmonti, S., Moschese, D., Fabbiani, M., Borghetti, A., Ciccullo, A., Visconti, E., & Giambenedetto, S. D. (2022) · HIV Research & Clinical Practice · doi:10.1080/25787489.2022.2080625 · Cited by 8
Robbertse, P. S., Doubell, A. F., Innes, S., Lombard, C. J., & Herbst, P. G. (2022) · Medicine · doi:10.1097/md.0000000000029721 · Cited by 8
Tincati, C., Basilissi, M., Sinigaglia, E., Merlini, E., Carpani, G., Monforte, A. D., & Marchetti, G. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110287 · Cited by 8
The clinical implications of HIV infection and aging
John, M. D. V. (2016) · Oral Diseases · doi:10.1111/odi.12473 · Cited by 9
Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection
Fulcher, J. A., Κούκος, Γ., Κουτσιούμπα, Μ., Elliott, J. E., Drakaki, A., Iliopoulos, D., & Anton, P. A. (2017) · AIDS · doi:10.1097/qad.0000000000001582 · Cited by 8
Thiébaut, R., Hüe, S., Marec, F. L., Lelièvre, J., Dupon, M., Foucat, E., Lazaro, E., Dabis, F., Duffau, P., Wittkop, L., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001628 · Cited by 8
Brummel‐Ziedins, K. E., Gissel, M., Neuhaus, J., Borges, Á. H., Chadwick, D. R., Emery, S., Neaton, J. D., Tracy, R. P., & Baker, J. V. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12147 · Cited by 8
Self-citationYanagisawa, N., Sasaki, S., Suganuma, A., Imamura, A., Ajisawa, A., & Ando, M. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.10.006 · Cited by 7
Keller, M. J., McGinn, A. P., Lo, Y., Huber, A. M., Espinoza, L., Minkoff, H., Colie, C. F., Nowicki, M. J., DʼSouza, G., & Anastos, K. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12518 · Cited by 7
Buck, A. M., Deveau, T., Henrich, T. J., & Deitchman, A. N. (2023) · Viruses · doi:10.3390/v15051126 · Cited by 9
Beginning Antiretroviral Therapy for Patients with HIV
Johnson, J. A., & Sax, P. E. (2014) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.06.003 · Cited by 7
Cardiovascular Disease in Patients with HIV
Knudsen, A., Kristoffersen, U. S., Kjær, A., & Lebech, A. (2012) · Future Virology · doi:10.2217/fvl.12.25 · Cited by 7
Schoffelen, A. F., Smit, C., van Lelyveld, S. F. L., Vogt, L., Bauer, M. P., Reiss, P., Hoepelman, A. I. M., & Barth, R. E. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv026 · Cited by 7
Evaluation of some haemostatic parameters infalciparummalaria and HIV co-infection
Chukwuanukwu, R. C., Ukaejiofo, E., Ele, P. U., Onyenekwe, C. C., Chukwuanukwu, T., & Ifeanyichukwu, M. (2016) · British Journal of Biomedical Science · doi:10.1080/09674845.2016.1202490 · Cited by 7
Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults
Sakoda, M., Fazeli, P. L., Ellis, R. J., Jeste, D. V., Grant, I., Letendre, S. L., & Moore, D. J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001235 · Cited by 8
Venuto, C. S., Lim, J., Messing, S. P., Hunt, P. W., McComsey, G. A., & Morse, G. D. (2017) · Antiviral Therapy · doi:10.3851/imp3209 · Cited by 7
Nozza, S., Pogliaghi, M., Chiappetta, S., Spagnuolo, V., Fontana, G., Razzari, C., Tambussi, G., & Faioni, E. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037032 · Cited by 7
Kafka, J. K., Osborne, B., Sheth, P. M., Nazli, A., Dizzell, S. E., Huibner, S., Kovacs, C. C., Verschoor, C. P., Bowdish, D. M. E., Kaul, R., et al. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12300 · Cited by 7
Association of Statin Use With Kidney Damage and Function Among HIV-Infected Men
Ascher, S. B., Scherzer, R., Nishtala, A., Jotwani, V., Grünfeld, C., Parikh, C. R., Ng, D. K., Wang, R., Palella, F. J., Shlipak, M. G., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002122 · Cited by 7
Self-citationHsu, D. C., Ma, Y. F., Narwan, A., Rahalkar, S., Rupert, A. W., Scherzer, R., Mills, C., Deeks, S. G., Sereti, I., & Hsue, P. Y. (2019) · AIDS · doi:10.1097/qad.0000000000002389 · Cited by 7
dos Reis, M. M. L., Queiroz, M. A. F., da Silva, B. C. M., Duarte, A. J. D. S., Casseb, J., Argañaraz, G. A., Vallinoto, A. C. R., & Argañaraz, E. R. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25651 · Cited by 8
Nakamura‐Hoshi, M., Takahara, Y., Matsuoka, S., Ishii, H., Seki, S., Nomura, T., Yamamoto, H., Sakawaki, H., Miura, T., Tokusumi, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68267-w · Cited by 7
Francesco, D. D., Sabin, C. A., Reiss, P., & Kootstra, N. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.581616 · Cited by 7
de Bouillé, J. G., Vigouroux, C., Plessis, L., Ghislain, M., Teglas, J., Boufassa, F., Goujard, C., Vignes, D., Bouchaud, O., Salmon, D., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab151 · Cited by 7
Ward, A. R., Thomas, A. S., Stevenson, E. M., Huang, S.-H., Keating, S. M., Gandhi, R. T., McMahon, D. K., Bosch, R. J., Macatangay, B. J. C., Cyktor, J. C., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003301 · Cited by 7
Chiappetta, S., Ripa, M., Galli, L., Razzari, C., Longo, V., Galli, A., Faioni, E. M., Nozza, S., Lazzarin, A., & Tambussi, G. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw010 · Cited by 7
Landowners’ Educational Needs and How Foresters Can Respond to Them
Kuhns, M. R., Brunson, M. W., & Roberts, S. D. (1998) · Digital Commons - USU (Utah State University) · doi:10.1093/jof/96.8.38 · Cited by 7
Gut microbiome variation in pulmonary TB patients with diabetes or HIV comorbidities
Morgan, P. A., Parbie, P. K., Ntiamoah, D. O., Boadu, A. A., Asare, P. P. A., Lamptey, I. N. K., Gorman, C. N., Afreh, E. K., Asante-Poku, A., Otchere, I. D., et al. (2023) · Frontiers in Microbiomes · doi:10.3389/frmbi.2023.1123064 · Cited by 8
Thirugnanam, S., & Rout, N. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050287 · Cited by 6
Choshi, J., Hanser, S., Mabhida, S. E., Mokoena, H., Moetlediwa, M. T., Muvhulawa, N., Sekgala, M. D., Nkambule, B. B., Mchiza, Z. J., Ndwandwe, D. E., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09594-5 · Cited by 6
O'Connor, J. B., Fouquier, J., Neff, C. P., Sterrett, J. D., Marden, T. J., Fiorillo, S. P., Siebert, J., Schneider, J. A., Nusbacher, N. M., Noe, A. T., et al. (2025) · mSystems · doi:10.1128/msystems.01185-25 · Cited by 6
Liao, C., Yang, C.-T., Chen, P.-H., Toh, H. S., Kuo, S., Chen, Z., Ou, H., Ko, N., & Wang, J. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320908085 · Cited by 6
Mazaheri, T., Buchanan, D., Hung, R. K. Y., Campbell, L. J., Hamzah, L., Bramham, K., Vincent, R. P., & Post, F. A. (2022) · AIDS · doi:10.1097/qad.0000000000003466 · Cited by 6
Obeagu, E. I., Esimai, B. N., Obeagu, G. U., Ochiabuto, O. M. T. B., Chukwurah, E. F., Ekelozie, I. S., & Ochei, K. (2020) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2020/v32i1330592 · Cited by 6
Sanuade, O. A., Baatiema, L., Christian, A. K., & Puplampu, P. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.38.317.28335 · Cited by 6
Qrareya, A. N., Wise, N. S., Hodges, E. R., Mahdi, F., Stewart, J. A., & Paris, J. J. (2022) · Viruses · doi:10.3390/v14102191 · Cited by 6
Belaunzarán-Zamudio, P. F., Naranjo, L., Caro-Vega, Y. N., Castillo‐Mancilla, J., Camiro-Zúñiga, A., Fuentes–García, R., Crabtree‐Ramírez, B., & Sierra-Madero, J. G. (2023) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2021.0179 · Cited by 6
Folorunso, O. M., Bocca, B., Ruggieri, F., Frazzoli, C., Chijioke-Nwauche, I. N., & Orisakwe, O. E. (2023) · Journal of Environmental Science and Health Part A · doi:10.1080/10934529.2023.2185004 · Cited by 6
Phatlhane, D. V., Ipp, H., Erasmus, R. T., & Zemlin, A. E. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0549 · Cited by 6
The Effect of Alcohol use on IL-6 Responses Across Different Racial/Ethnic Groups
Míguez, M. J., Rosenberg, R., Burbano-Levy, X., Carmona, T., & Malow, R. M. (2012) · Future Virology · doi:10.2217/fvl.12.3 · Cited by 6
Hullsiek, K. H., George, M., & Brown, S. K. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833f2058 · Cited by 6
Cardiovascular Complications of HIV
Zanetti, H. R., Roever, L., Gonçalves, A., & Resende, E. S. (2018) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20180049 · Cited by 6
Human Immunodeficiency Virus Infection
Patel, P., Raizes, E. G., & Broyles, L. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-55512-8.00031-4 · Cited by 8
Human Immunodeficiency Virus Persistence in the Spleen: Opportunities for Pharmacologic Intervention
Devanathan, A. S., & Kashuba, A. D. M. (2021) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0266 · Cited by 6
Villar, S. S., Cohen, C. J., Baker, J. V., Janeiro, M. J., Aragão, F., Melbourne, K. M., González, J. L., Lara, L., Kim, C., & Moreno, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.976564 · Cited by 6
Self-citationEscota, G. V., & Önen, N. F. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10062471 · Cited by 6
The Effect of HIV and Art on the Development of Hypertension and Type 2 Diabetes Mellitus
Maseko, T., & Masuku, S. (2017) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000732 · Cited by 7
IMMUNITY ACTIVATION IN HIV INFECTION
Владимирович, Ш. К., Геннадьевна, Ш. Н., & Черешнев, В. А. (2017) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2017-5-489-504 · Cited by 6
Lim, H., Kane, L., Schwartz, J. B., Hesdorffer, C. S., Deeks, S. G., Greig, N. H., Ferrucci, L., & Goetzl, E. J. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04603.x · Cited by 6
Llibre, J. M., Antela, A., Arribas, J. R., Domingo, P., Gatell, J. M., López-Aldeguer, J., Lozano, F., Miralles, C., Moltó, J., Moreno, S., et al. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2010.08.004 · Cited by 6
Zungsontiporn, N., Ndhlovu, L. C., Mitchell, B. I., Stein, J. H., Kallianpur, K. J., Nakamoto, B. K., Keating, S. M., Norris, P. J., Souza, S. A., Shikuma, C. M., et al. (2015) · HIV Clinical Trials · doi:10.1080/15284336.2015.1123943 · Cited by 6
Associations between serum albumin and serious non-AIDS events among people living with HIV
Ronit, A., Hatleberg, C. I., Ryom, L., Bonnet, F., El-Sadr, W. M., Reiss, P., Weber, R., Pradier, C., Wit, S. D., Law, M. G., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001900 · Cited by 6
A deeper dive into the REPRIEVE trial and the potential role of inflammation in residual risk
Kalra, D. K. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.09.006 · Cited by 6
Dushoff, M., Bowdish, D. M. E., Zhabokritsky, A., Lovblom, L. E., Klein, M. B., Boyachuk, B., Falutz, J., Loutfy, M. R., Smith, G. H. R., Tan, D. H. S., et al. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06891-9 · Cited by 5
Míguez, M. J. (2012) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000e109 · Cited by 5
Nana, B. C., Esemu, L. F., Besong, M., Atchombat, D. H. N., Ogai, K., Sobgui, T. M. P., Nana, C. M. M., Seumko’o, R. M. N., Awanakan, H., Ekali, G. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1216480 · Cited by 5
The Negative Impact of Maternal HIV Infection on Birth Outcomes—Myth or Reality?
Fleșeriu, T., Meliţ, L. E., Mărginean, C. O., & Văsieșiu, A.-M. (2024) · Pathogens · doi:10.3390/pathogens13090808 · Cited by 5
Integrative biomarkers of biologic aging in HIV
Rajasuriar, R., Palmer, C. S., Abdel‐Mohsen, M., & Kamaruzzaman, S. B. (2018) · AIDS · doi:10.1097/qad.0000000000002064 · Cited by 5
HIV infection and cardiovascular pathology
Shekhovtsova, T. A., & Duplyakov, D. V. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3370 · Cited by 5
Evaluation of some immune and inflammatory responses in diabetes and HIV co-morbidity
Chukwuanukwu, R. C., Nwosu, N., Ositadinma, I. M., Nsonwu-Anyanwu, A. C., & Manafa, P. (2023) · African Health Sciences · doi:10.4314/ahs.v23i1.14 · Cited by 5
Boger, M. S., Bian, A., Shintani, A., Milne, G. L., Morrow, J. D., Erdem, H., Mitchell, V. M., Haas, D. W., & Hulgan, T. (2011) · Antiviral Therapy · doi:10.3851/imp1990 · Cited by 5
Metadata
- Authors
- Neuhaus, J., Jacobs, Jr., Baker, J. V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L. H., Pett, S. L., Ristola, M., Ross, M. J., Shlipak, M. G., Tracy, R., & Neaton, J. D.
- Affiliations
- University of Minnesota (US)
- University of Geneva (CH)
- University of Pittsburgh (US)
- UNSW Sydney (AU)
- University of Helsinki (FI)
- Icahn School of Medicine at Mount Sinai (US)
- University of California, San Francisco (US)
- University of Vermont (US)
- Corresponding author
- Neuhaus, Jacqueline
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06-15
- Volume
- 201
- Issue
- 12
- Pages
- 1788-1795
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC2872049
- OpenAlex
- W2127517680
- Cited by
- 869
- References
- 33
- Citations by year
- 2026: 29 · 2025: 25 · 2024: 30 · 2023: 50 · 2022: 59 · 2021: 49 · 2020: 60 · 2019: 54 · 2018: 53 · 2017: 66 · 2016: 58 · 2015: 65 · 2014: 68 · 2013: 67 · 2012: 69
- FWCI
- 61.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (n01hc95095-66-0-1, n01hc95164-17-0-1, n01hc48050-59-0-1, n01hc48048-58-0-1, n01hc95165-34-0-1, n01hc48047-55-0-1, n01hc95161-24-0-1, n01hc095169-003, n01hc95166-21-0-1, n01hc48049-61-0-1, n01hc95162-31-0-1, n01hc95168-27-0-1, n01hc95160-18-0-1, n01hc095167-000, N01-HC- 95159, n01hc95163-22-0-1, n01hc95159-40-0-1, N01‐HC‐95169)
- National Heart, Lung, and Blood Institute (N01HC48050, N01 HC-95159, N01-HC095169, N01-HC-095165, N01 HC 95095, N01 HC095163, N01 HC048048, N01-HC-048049, N01-HC-095159, N01 HC095168, NO1-HC-48049, N01-HC-095162, N01 HC095095, N01-HC-095161, N01 HC048050, N01-HC48048, N01 HC095167, N01-HC-48-049, N01-HC-095160, N01 HC095166, N01 HC095164, N01 HC048047, NO1-HC-95095, N01-HC-480-47, N01 HC95169)
- National Institute of Allergy and Infectious Diseases (U01 AI46362, U01AI046362, U01AI042170)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078510)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV infection, inflammatory markers, coagulation markers, renal function, high-sensitivity C-reactive protein, interleukin-6, D-dimer, cystatin C, antiretroviral therapy, viral suppression, immune activation, cardiovascular risk
- MeSH terms
- Adult, Aged, Blood Coagulation Disorders, C-Reactive Protein, Female, Fibrin Fibrinogen Degradation Products, Humans, Inflammation, Kidney Diseases, Male, Middle Aged, Biomarkers, HIV Infections, Interleukin-6, Anti-HIV Agents, Viral Load, Cystatin C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review